Your browser doesn't support javascript.
loading
Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
Velders, Matthijs A; Abtan, Jérémie; Angiolillo, Dominick J; Ardissino, Diego; Harrington, Robert A; Hellkamp, Anne; Himmelmann, Anders; Husted, Steen; Katus, Hugo A; Meier, Bernhard; Schulte, Phillip J; Storey, Robert F; Wallentin, Lars; Gabriel Steg, Philippe; James, Stefan K.
Afiliação
  • Velders MA; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Abtan J; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France.
  • Angiolillo DJ; Department of Medicine, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA.
  • Ardissino D; Azienda Ospedaliero, Universitaria di Parma, Parma, Italy.
  • Harrington RA; Department of Medicine, Stanford University, Stanford, California, USA.
  • Hellkamp A; Duke Clinical Research Institute, Duke University, Medical Center, Durham, North Carolina, USA.
  • Himmelmann A; AstraZeneca Research and Development, Gothenburg, Sweden.
  • Husted S; Medical Department, Hospital Unit West, Holstebro - Herning/Holstebro, Denmark.
  • Katus HA; Medizinishe Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Meier B; Bern University Hospital, Bern, Switzerland.
  • Schulte PJ; Duke Clinical Research Institute, Duke University, Medical Center, Durham, North Carolina, USA Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Storey RF; Department of Cardiovascular Science, University of Sheffield, Sheffield, UK.
  • Wallentin L; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Gabriel Steg P; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France INSERM-Unité 1148, Paris, France Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France NHLI Imperial College, ICMS, Royal Brompton Hospital, London, UK.
  • James SK; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Heart ; 102(8): 617-25, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26848185
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ticlopidina / Inibidores da Agregação Plaquetária / Adenosina / Intervenção Coronária Percutânea / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Heart Assunto da revista: CARDIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ticlopidina / Inibidores da Agregação Plaquetária / Adenosina / Intervenção Coronária Percutânea / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Heart Assunto da revista: CARDIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia